Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009 View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2010-12

AUTHORS

Vernon J Lee, Jonathan Yap, Joshua K Tay, Ian Barr, Qiuhan Gao, Hanley J Ho, Boon Huan Tan, Paul M Kelly, Paul A Tambyah, Anne Kelso, Mark I Chen

ABSTRACT

BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis. METHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing--at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms. RESULTS: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted. CONCLUSIONS: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks. More... »

PAGES

164

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/1471-2334-10-164

DOI

http://dx.doi.org/10.1186/1471-2334-10-164

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1028454525

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/20537158


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Adult", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antibodies, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Antiviral Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Chemoprevention", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cohort Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Disease Outbreaks", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hemagglutination Inhibition Tests", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza A Virus, H1N1 Subtype", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Influenza, Human", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Military Personnel", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Nasopharynx", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Oseltamivir", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "RNA, Viral", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Reverse Transcriptase Polymerase Chain Reaction", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Singapore", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Surveys and Questionnaires", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Young Adult", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Australian National University", 
          "id": "https://www.grid.ac/institutes/grid.1001.0", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore", 
            "Centre for Health Services Research, National University of Singapore, Medical Drive, 117597, Singapore, Singapore", 
            "Department of Epidemiology and Public Health, National University of Singapore, Medical Drive, 117597, Singapore, Singapore", 
            "National Centre for Epidemiology and Population Health, Australian National University, 0200, Canberra, ACT, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lee", 
        "givenName": "Vernon J", 
        "id": "sg:person.0760054051.35", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760054051.35"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yap", 
        "givenName": "Jonathan", 
        "id": "sg:person.01124670776.47", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124670776.47"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tay", 
        "givenName": "Joshua K", 
        "id": "sg:person.01150570333.36", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150570333.36"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Victorian Infectious Diseases Reference Laboratory", 
          "id": "https://www.grid.ac/institutes/grid.433799.3", 
          "name": [
            "WHO Collaborating Center for Reference and Research for Influenza, Wreckyn Street, 3051, North Melbourne, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barr", 
        "givenName": "Ian", 
        "id": "sg:person.01302120514.26", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302120514.26"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gao", 
        "givenName": "Qiuhan", 
        "id": "sg:person.0616265467.10", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616265467.10"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Ministry of Defence", 
          "id": "https://www.grid.ac/institutes/grid.452314.5", 
          "name": [
            "Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Ho", 
        "givenName": "Hanley J", 
        "id": "sg:person.01024306167.31", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024306167.31"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "DSO National Laboratories", 
          "id": "https://www.grid.ac/institutes/grid.410760.4", 
          "name": [
            "Detection and Diagnostics Laboratory, Defence Medical and Environmental Research Institute, DSO National Laboratories, Medical Drive, 117510, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "Boon Huan", 
        "id": "sg:person.01272172631.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272172631.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Australian National University", 
          "id": "https://www.grid.ac/institutes/grid.1001.0", 
          "name": [
            "National Centre for Epidemiology and Population Health, Australian National University, 0200, Canberra, ACT, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kelly", 
        "givenName": "Paul M", 
        "id": "sg:person.0672012164.38", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672012164.38"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "National University of Singapore", 
          "id": "https://www.grid.ac/institutes/grid.4280.e", 
          "name": [
            "Division of Infectious Diseases, National University of Singapore, Lower Kent Ridge Road, 119074, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tambyah", 
        "givenName": "Paul A", 
        "id": "sg:person.010711506654.18", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010711506654.18"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Victorian Infectious Diseases Reference Laboratory", 
          "id": "https://www.grid.ac/institutes/grid.433799.3", 
          "name": [
            "WHO Collaborating Center for Reference and Research for Influenza, Wreckyn Street, 3051, North Melbourne, Victoria, Australia"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kelso", 
        "givenName": "Anne", 
        "id": "sg:person.0645000227.41", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645000227.41"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Tan Tock Seng Hospital", 
          "id": "https://www.grid.ac/institutes/grid.240988.f", 
          "name": [
            "Department of Clinical Epidemiology, Tan Tock Seng Hospital, Jalan Tan Tock Seng, 308433, Singapore, Singapore"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Chen", 
        "givenName": "Mark I", 
        "id": "sg:person.0634357115.84", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634357115.84"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.3201/eid1303.060309", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1005952153"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/381128", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006220379"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(03)14854-4", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1008859942"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1046/j.1532-5415.2001.49204.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012005473"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.285.6.748", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1012848872"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm199910283411802", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1016534245"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3201/eid0703.010320", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024823460"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1001/jama.2010.404", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027739937"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0906089", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1030448983"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1086/345722", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032715119"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/s0140-6736(09)62126-7", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039880362"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0905498", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042060084"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2799", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802496"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2897", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1136/bmj.b2897", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1062802581"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1077927377", 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://app.dimensions.ai/details/publication/pub.1079644865", 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2010-12", 
    "datePublishedReg": "2010-12-01", 
    "description": "BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis.\nMETHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing--at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms.\nRESULTS: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted.\nCONCLUSIONS: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/1471-2334-10-164", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1024946", 
        "issn": [
          "1471-2334"
        ], 
        "name": "BMC Infectious Diseases", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "10"
      }
    ], 
    "name": "Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009", 
    "pagination": "164", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "878cbfb13e7413abf070a05e9c30da11df8b3b3a209593d3dc41d8f0805ffa9b"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "20537158"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "100968551"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/1471-2334-10-164"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1028454525"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/1471-2334-10-164", 
      "https://app.dimensions.ai/details/publication/pub.1028454525"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T01:14", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000001_0000000264/records_8697_00000550.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "http://link.springer.com/10.1186%2F1471-2334-10-164"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/1471-2334-10-164'


 

This table displays all metadata directly associated to this object as RDF triples.

278 TRIPLES      21 PREDICATES      64 URIs      40 LITERALS      28 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/1471-2334-10-164 schema:about N17e938f310c646ffa40aadc34e4b4bc4
2 N1ad7aed71c5a4bf6b34f9b1289c1e813
3 N3b25d800fc1644d59ebca8fafc41025d
4 N46bbf81fb0a74a1d9b9d2708bcf12d78
5 N4e9af4057b6f448585318692069f688a
6 N51a19a9453df42eda7af1c6282d597da
7 N51a46897d83048108717722c73010093
8 N5a69f99ee42640aa8dc02f9cb94c8f3c
9 N5d39b58b946b4af48b00140e34f9ad27
10 N7c9f43e34d724bf99967f30fe1c8e5a2
11 N80744f3ff69b4a96b04a668f6643a6b4
12 N87c855eb78724838bad0bafbe9476635
13 N8b4ebea6cfbd4d049433f110e105a5a1
14 N8d94a84692214b279bbabd5ae5ef72d8
15 N8ecfae37879a4605a6c80464ad0327d7
16 Nab00e636ef314a21b452df6f852afe55
17 Nab702aa2f2b64d5c8514eec4a4adaf1e
18 Nad4fc247e90d465195d1f6bfe0b8ce7c
19 Nad6974c76c2f4b7cbbc4230611f16d66
20 anzsrc-for:11
21 anzsrc-for:1117
22 schema:author Ne6aa1628f9e54d7d91f9839435add32d
23 schema:citation https://app.dimensions.ai/details/publication/pub.1077927377
24 https://app.dimensions.ai/details/publication/pub.1079644865
25 https://doi.org/10.1001/jama.2010.404
26 https://doi.org/10.1001/jama.285.6.748
27 https://doi.org/10.1016/s0140-6736(03)14854-4
28 https://doi.org/10.1016/s0140-6736(09)62126-7
29 https://doi.org/10.1046/j.1532-5415.2001.49204.x
30 https://doi.org/10.1056/nejm199910283411802
31 https://doi.org/10.1056/nejmoa0905498
32 https://doi.org/10.1056/nejmoa0906089
33 https://doi.org/10.1086/345722
34 https://doi.org/10.1086/381128
35 https://doi.org/10.1136/bmj.b2799
36 https://doi.org/10.1136/bmj.b2897
37 https://doi.org/10.3201/eid0703.010320
38 https://doi.org/10.3201/eid1303.060309
39 schema:datePublished 2010-12
40 schema:datePublishedReg 2010-12-01
41 schema:description BACKGROUND: Anti-viral prophylaxis is used to prevent the transmission of influenza. We studied serological confirmation of 2009 Influenza A (H1N1) infections during oseltamivir prophylaxis and after cessation of prophylaxis. METHODS: Between 22 Jun and 16 Jul 09, we performed a cohort study in 3 outbreaks in the Singapore military where post-exposure oseltamivir ring chemoprophylaxis (75 mg daily for 10 days) was administered. The entire cohort was screened by RT-PCR (with HA gene primers) using nasopharyngeal swabs three times a week. Three blood samples were taken for haemagglutination inhibition testing--at the start of outbreak, 2 weeks after completion of 10 day oseltamivir prophylaxis, and 3 weeks after the pandemic's peak in Singapore. Questionnaires were also administered to collect clinical symptoms. RESULTS: 237 personnel were included for analysis. The overall infection rate of 2009 Influenza A (H1N1) during the three outbreaks was 11.4% (27/237). This included 11 index cases and 16 personnel (7.1%) who developed four-fold or higher rise in antibody titres during oseltamivir prophylaxis. Of these 16 personnel, 8 (3.5%) were symptomatic while the remaining 8 personnel (3.5%) were asymptomatic and tested negative on PCR. Post-cessation of prophylaxis, an additional 23 (12.1%) seroconverted. There was no significant difference in mean fold-rise in GMT between those who seroconverted during and post-prophylaxis (11.3 vs 11.7, p = 0.888). No allergic, neuropsychiatric or other severe side-effects were noted. CONCLUSIONS: Post-exposure oseltamivir prophylaxis reduced the rate of infection during outbreaks, and did not substantially increase subsequent infection rates upon cessation. Asymptomatic infections occur during prophylaxis, which may confer protection against future infection. Post-exposure prophylaxis is effective as a measure in mitigating pandemic influenza outbreaks.
42 schema:genre research_article
43 schema:inLanguage en
44 schema:isAccessibleForFree true
45 schema:isPartOf N07d8584bc47c4afeaa63f5bbee311a5f
46 N9344901b70e844d4ac653fc50cb27491
47 sg:journal.1024946
48 schema:name Seroconversion and asymptomatic infections during oseltamivir prophylaxis against Influenza A H1N1 2009
49 schema:pagination 164
50 schema:productId N0012efd2209846c3b747281dff21aa0c
51 N0d494c6d226c401cae0844ca2850bf4b
52 N2f564d030e0c466593ea6731f72fb8f9
53 N42cc82508c304c23a9c7d8dcd6f4c0c7
54 Naf390d8f35fb4bc2b6fd7ee689395420
55 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028454525
56 https://doi.org/10.1186/1471-2334-10-164
57 schema:sdDatePublished 2019-04-11T01:14
58 schema:sdLicense https://scigraph.springernature.com/explorer/license/
59 schema:sdPublisher N5fe3675214b04694813c599e64b37a54
60 schema:url http://link.springer.com/10.1186%2F1471-2334-10-164
61 sgo:license sg:explorer/license/
62 sgo:sdDataset articles
63 rdf:type schema:ScholarlyArticle
64 N0012efd2209846c3b747281dff21aa0c schema:name dimensions_id
65 schema:value pub.1028454525
66 rdf:type schema:PropertyValue
67 N07d8584bc47c4afeaa63f5bbee311a5f schema:volumeNumber 10
68 rdf:type schema:PublicationVolume
69 N0d494c6d226c401cae0844ca2850bf4b schema:name doi
70 schema:value 10.1186/1471-2334-10-164
71 rdf:type schema:PropertyValue
72 N17e938f310c646ffa40aadc34e4b4bc4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
73 schema:name Reverse Transcriptase Polymerase Chain Reaction
74 rdf:type schema:DefinedTerm
75 N191fecfdb8cb4e59a59ea91ae4234749 rdf:first sg:person.0672012164.38
76 rdf:rest N3ebc3dc2745f45ef99f711cfd64e75a6
77 N1ad7aed71c5a4bf6b34f9b1289c1e813 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Cohort Studies
79 rdf:type schema:DefinedTerm
80 N2d28f982548344b9bc5c7b6f9b6aeffa rdf:first sg:person.01302120514.26
81 rdf:rest Nc2f484908ab34257aece1f2791b34bbd
82 N2f564d030e0c466593ea6731f72fb8f9 schema:name pubmed_id
83 schema:value 20537158
84 rdf:type schema:PropertyValue
85 N3b25d800fc1644d59ebca8fafc41025d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
86 schema:name Oseltamivir
87 rdf:type schema:DefinedTerm
88 N3ebc3dc2745f45ef99f711cfd64e75a6 rdf:first sg:person.010711506654.18
89 rdf:rest Nd3c6ec9114a1454296c476898d48d86b
90 N42cc82508c304c23a9c7d8dcd6f4c0c7 schema:name nlm_unique_id
91 schema:value 100968551
92 rdf:type schema:PropertyValue
93 N46bbf81fb0a74a1d9b9d2708bcf12d78 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
94 schema:name Surveys and Questionnaires
95 rdf:type schema:DefinedTerm
96 N4e9af4057b6f448585318692069f688a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
97 schema:name Hemagglutination Inhibition Tests
98 rdf:type schema:DefinedTerm
99 N51a19a9453df42eda7af1c6282d597da schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
100 schema:name Singapore
101 rdf:type schema:DefinedTerm
102 N51a46897d83048108717722c73010093 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
103 schema:name Influenza A Virus, H1N1 Subtype
104 rdf:type schema:DefinedTerm
105 N56542d2b89c74fa3b48b65cdb4113c6f rdf:first sg:person.01150570333.36
106 rdf:rest N2d28f982548344b9bc5c7b6f9b6aeffa
107 N5a69f99ee42640aa8dc02f9cb94c8f3c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
108 schema:name Young Adult
109 rdf:type schema:DefinedTerm
110 N5cc207c42a04487cbf98fa7ff160d4ea rdf:first sg:person.01124670776.47
111 rdf:rest N56542d2b89c74fa3b48b65cdb4113c6f
112 N5d39b58b946b4af48b00140e34f9ad27 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
113 schema:name Military Personnel
114 rdf:type schema:DefinedTerm
115 N5fe3675214b04694813c599e64b37a54 schema:name Springer Nature - SN SciGraph project
116 rdf:type schema:Organization
117 N7c9f43e34d724bf99967f30fe1c8e5a2 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
118 schema:name Influenza, Human
119 rdf:type schema:DefinedTerm
120 N7d29c9bc4c02495f97d68958e5f1dc8a rdf:first sg:person.0634357115.84
121 rdf:rest rdf:nil
122 N80744f3ff69b4a96b04a668f6643a6b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
123 schema:name RNA, Viral
124 rdf:type schema:DefinedTerm
125 N87c855eb78724838bad0bafbe9476635 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
126 schema:name Humans
127 rdf:type schema:DefinedTerm
128 N8b4ebea6cfbd4d049433f110e105a5a1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
129 schema:name Male
130 rdf:type schema:DefinedTerm
131 N8d94a84692214b279bbabd5ae5ef72d8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
132 schema:name Adult
133 rdf:type schema:DefinedTerm
134 N8ecfae37879a4605a6c80464ad0327d7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
135 schema:name Nasopharynx
136 rdf:type schema:DefinedTerm
137 N9344901b70e844d4ac653fc50cb27491 schema:issueNumber 1
138 rdf:type schema:PublicationIssue
139 Naa192f3e6bd34ba9b8f33b0acef6d6a1 rdf:first sg:person.01024306167.31
140 rdf:rest Ncdc1372c8eb845ce954fd382f08c0409
141 Nab00e636ef314a21b452df6f852afe55 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
142 schema:name Disease Outbreaks
143 rdf:type schema:DefinedTerm
144 Nab702aa2f2b64d5c8514eec4a4adaf1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Antibodies, Viral
146 rdf:type schema:DefinedTerm
147 Nad4fc247e90d465195d1f6bfe0b8ce7c schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Antiviral Agents
149 rdf:type schema:DefinedTerm
150 Nad6974c76c2f4b7cbbc4230611f16d66 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Chemoprevention
152 rdf:type schema:DefinedTerm
153 Naf390d8f35fb4bc2b6fd7ee689395420 schema:name readcube_id
154 schema:value 878cbfb13e7413abf070a05e9c30da11df8b3b3a209593d3dc41d8f0805ffa9b
155 rdf:type schema:PropertyValue
156 Nc2f484908ab34257aece1f2791b34bbd rdf:first sg:person.0616265467.10
157 rdf:rest Naa192f3e6bd34ba9b8f33b0acef6d6a1
158 Ncdc1372c8eb845ce954fd382f08c0409 rdf:first sg:person.01272172631.41
159 rdf:rest N191fecfdb8cb4e59a59ea91ae4234749
160 Nd3c6ec9114a1454296c476898d48d86b rdf:first sg:person.0645000227.41
161 rdf:rest N7d29c9bc4c02495f97d68958e5f1dc8a
162 Ne6aa1628f9e54d7d91f9839435add32d rdf:first sg:person.0760054051.35
163 rdf:rest N5cc207c42a04487cbf98fa7ff160d4ea
164 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
165 schema:name Medical and Health Sciences
166 rdf:type schema:DefinedTerm
167 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
168 schema:name Public Health and Health Services
169 rdf:type schema:DefinedTerm
170 sg:journal.1024946 schema:issn 1471-2334
171 schema:name BMC Infectious Diseases
172 rdf:type schema:Periodical
173 sg:person.01024306167.31 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
174 schema:familyName Ho
175 schema:givenName Hanley J
176 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01024306167.31
177 rdf:type schema:Person
178 sg:person.010711506654.18 schema:affiliation https://www.grid.ac/institutes/grid.4280.e
179 schema:familyName Tambyah
180 schema:givenName Paul A
181 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010711506654.18
182 rdf:type schema:Person
183 sg:person.01124670776.47 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
184 schema:familyName Yap
185 schema:givenName Jonathan
186 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01124670776.47
187 rdf:type schema:Person
188 sg:person.01150570333.36 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
189 schema:familyName Tay
190 schema:givenName Joshua K
191 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01150570333.36
192 rdf:type schema:Person
193 sg:person.01272172631.41 schema:affiliation https://www.grid.ac/institutes/grid.410760.4
194 schema:familyName Tan
195 schema:givenName Boon Huan
196 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01272172631.41
197 rdf:type schema:Person
198 sg:person.01302120514.26 schema:affiliation https://www.grid.ac/institutes/grid.433799.3
199 schema:familyName Barr
200 schema:givenName Ian
201 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01302120514.26
202 rdf:type schema:Person
203 sg:person.0616265467.10 schema:affiliation https://www.grid.ac/institutes/grid.452314.5
204 schema:familyName Gao
205 schema:givenName Qiuhan
206 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0616265467.10
207 rdf:type schema:Person
208 sg:person.0634357115.84 schema:affiliation https://www.grid.ac/institutes/grid.240988.f
209 schema:familyName Chen
210 schema:givenName Mark I
211 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0634357115.84
212 rdf:type schema:Person
213 sg:person.0645000227.41 schema:affiliation https://www.grid.ac/institutes/grid.433799.3
214 schema:familyName Kelso
215 schema:givenName Anne
216 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0645000227.41
217 rdf:type schema:Person
218 sg:person.0672012164.38 schema:affiliation https://www.grid.ac/institutes/grid.1001.0
219 schema:familyName Kelly
220 schema:givenName Paul M
221 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0672012164.38
222 rdf:type schema:Person
223 sg:person.0760054051.35 schema:affiliation https://www.grid.ac/institutes/grid.1001.0
224 schema:familyName Lee
225 schema:givenName Vernon J
226 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0760054051.35
227 rdf:type schema:Person
228 https://app.dimensions.ai/details/publication/pub.1077927377 schema:CreativeWork
229 https://app.dimensions.ai/details/publication/pub.1079644865 schema:CreativeWork
230 https://doi.org/10.1001/jama.2010.404 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027739937
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1001/jama.285.6.748 schema:sameAs https://app.dimensions.ai/details/publication/pub.1012848872
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1016/s0140-6736(03)14854-4 schema:sameAs https://app.dimensions.ai/details/publication/pub.1008859942
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1016/s0140-6736(09)62126-7 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039880362
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1046/j.1532-5415.2001.49204.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1012005473
239 rdf:type schema:CreativeWork
240 https://doi.org/10.1056/nejm199910283411802 schema:sameAs https://app.dimensions.ai/details/publication/pub.1016534245
241 rdf:type schema:CreativeWork
242 https://doi.org/10.1056/nejmoa0905498 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042060084
243 rdf:type schema:CreativeWork
244 https://doi.org/10.1056/nejmoa0906089 schema:sameAs https://app.dimensions.ai/details/publication/pub.1030448983
245 rdf:type schema:CreativeWork
246 https://doi.org/10.1086/345722 schema:sameAs https://app.dimensions.ai/details/publication/pub.1032715119
247 rdf:type schema:CreativeWork
248 https://doi.org/10.1086/381128 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006220379
249 rdf:type schema:CreativeWork
250 https://doi.org/10.1136/bmj.b2799 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062802496
251 rdf:type schema:CreativeWork
252 https://doi.org/10.1136/bmj.b2897 schema:sameAs https://app.dimensions.ai/details/publication/pub.1062802581
253 rdf:type schema:CreativeWork
254 https://doi.org/10.3201/eid0703.010320 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024823460
255 rdf:type schema:CreativeWork
256 https://doi.org/10.3201/eid1303.060309 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005952153
257 rdf:type schema:CreativeWork
258 https://www.grid.ac/institutes/grid.1001.0 schema:alternateName Australian National University
259 schema:name Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore
260 Centre for Health Services Research, National University of Singapore, Medical Drive, 117597, Singapore, Singapore
261 Department of Epidemiology and Public Health, National University of Singapore, Medical Drive, 117597, Singapore, Singapore
262 National Centre for Epidemiology and Population Health, Australian National University, 0200, Canberra, ACT, Australia
263 rdf:type schema:Organization
264 https://www.grid.ac/institutes/grid.240988.f schema:alternateName Tan Tock Seng Hospital
265 schema:name Department of Clinical Epidemiology, Tan Tock Seng Hospital, Jalan Tan Tock Seng, 308433, Singapore, Singapore
266 rdf:type schema:Organization
267 https://www.grid.ac/institutes/grid.410760.4 schema:alternateName DSO National Laboratories
268 schema:name Detection and Diagnostics Laboratory, Defence Medical and Environmental Research Institute, DSO National Laboratories, Medical Drive, 117510, Singapore, Singapore
269 rdf:type schema:Organization
270 https://www.grid.ac/institutes/grid.4280.e schema:alternateName National University of Singapore
271 schema:name Division of Infectious Diseases, National University of Singapore, Lower Kent Ridge Road, 119074, Singapore, Singapore
272 rdf:type schema:Organization
273 https://www.grid.ac/institutes/grid.433799.3 schema:alternateName Victorian Infectious Diseases Reference Laboratory
274 schema:name WHO Collaborating Center for Reference and Research for Influenza, Wreckyn Street, 3051, North Melbourne, Victoria, Australia
275 rdf:type schema:Organization
276 https://www.grid.ac/institutes/grid.452314.5 schema:alternateName Ministry of Defence
277 schema:name Biodefence Centre, Ministry of Defence, Transit Road, 778910, Singapore, Singapore
278 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...